A condition marked by the presence of multiple osteochondromas. (Dorland, 27th ed)
| Synonym |
|---|
| Osteochondromatosis |
| Timeframe | Studies, This Condition (%) | All Conditions % |
|---|---|---|
| pre-1990 | 0 (0.00) | 23.3326 |
| 1990's | 2 (28.57) | 12.5806 |
| 2000's | 3 (42.86) | 18.1394 |
| 2010's | 2 (28.57) | 28.8240 |
| 2020's | 0 (0.00) | 9.53 |
| Drug | Indicated | Relationship Strength | Studies | Trials |
|---|---|---|---|---|
| technetium | 0 | low | 1 | 0 |
| trolamine salicylate | 0 | low | 2 | 0 |
| technetium 99m | 0 | low | 1 | 0 |
| technetium tc 99m hydroxymethylene diphosphonate | 0 | low | 1 | 0 |
| gadolinium dtpa | 0 | low | 1 | 0 |
| technetium tc 99m medronate | 0 | low | 1 | 0 |
| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|---|---|---|---|
| RAR-related orphan receptor gamma | 1 | 0 | 0 | 1 |
| retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | ||||